Cite
HARVARD Citation
Castañon, E. et al. (2020). Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings. European journal of cancer. pp. 159-168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Castañon, E. et al. (2020). Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings. European journal of cancer. pp. 159-168. [Online].